New Multi-Marker Blood Test from Lucent Diagnostics Increases the Number of Patients Receiving Early Alzheimer's Disease Diagnostic Information

LucentAD(TM) Complete improves on single biomarker tests, significantly reducing the intermediate zone, providing results for more patients BILLERICA, Mass. -- Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), has [...]